Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571.

被引：0
|
作者：
Klejman, A
Rushen, L
Morrione, A
Slupianek, A
Skorski, T
机构：
[1] Temple Univ, Ctr Biotechnol, Philadelphia, PA 19122 USA
[2] Kimmel Canc Ctr, Philadelphia, PA USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
616
引用
收藏
页码：146A / 146A
页数：1
相关论文
共 50 条
  • [21] Effect of inhibitors of phosphatidylinositol 3-OH kinase on in vitro juvenile myelomonocytic leukemia cell growth.
    Snyder, RC
    Gopurala, B
    Wiley, T
    Castleberry, RP
    Emanuel, PD
    BLOOD, 1998, 92 (10) : 426A - 427A
  • [22] The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Brown, Jennifer R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 807 - 826
  • [23] Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen
    I-Chun Chen
    Li-Ping Hsiao
    I-Wen Huang
    Huei-Chieh Yu
    Ling-Chun Yeh
    Ching-Hung Lin
    Tom Wei-Wu Chen
    Ann-Lii Cheng
    Yen-Shen Lu
    Scientific Reports, 7
  • [24] Evaluation of anti-leukemia effect of resveratrol by modulating SATA3 signaling
    Li, Tan
    Wang, Wei
    Chen, Hong
    Li, Tong
    Ye, Lu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (01) : 18 - 25
  • [25] Inhibition of oncogenic FLT3 to enhance anti-leukemia responses via IL-15
    Mathew, N.
    Finke, J.
    Duyster, J.
    Zeiser, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 41 - 41
  • [26] Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax
    Liu, Hongcai
    Hussain, Zubair
    Xie, Qingqing
    Yan, Xueying
    Zeng, Chenxing
    Zhou, Gan
    Cao, Shan
    EXPERIMENTAL CELL RESEARCH, 2022, 417 (02)
  • [27] Inhibitory effect of insulin on cAMP response in hepatocytes:: Role of the phosphatidylinositol-3′kinase and of the transcription factor FKHR
    Groyer, G
    Cadepond, F
    Grover, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 70 - 70
  • [28] SPECIFIC INHIBITORS OF CASEIN KINASE 2 (CK2) INDUCE A STRONG ANTI-LEUKEMIA EFFECT BY ENHANCING THE TUMOR SUPPRESSOR ACTIVITY OF IKAROS
    Dovat, S.
    Song, C.
    Payne, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 26 - 26
  • [29] Phosphatidylinositol-3 kinase contributes to the activation of Stat3 in M1 leukemia cells induced by IL-6
    Zhang, JY
    Shen, BF
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2000, 32 (04): : 406 - 408
  • [30] Gene expression profiles of leukemic cells isolated from patients with chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia (PH+ ALL) receiving the Abl-kinase inhibitor STI571.
    von Bubnoff, N
    Schneller, F
    Peschel, C
    Duyster, J
    BLOOD, 2001, 98 (11) : 567A - 567A
12345